Class I · High risk
Thyroid Tablets
Superpotent Drug
WP Thyroid
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
What was recalled
WP Thyroid, Westhroid Pure, 1.75 Grain (113.75 mg) Thyroid USP, packaged in a) 1,000 Tablets, NDC 64727-6150-2 ; b) 30 Tablets, NDC 64727-6150-4; c) 60 Tablets, NDC 64727-6150-5; d) 90 Tablets, NDC 64727-6150-6; e) 100 Tablets, NDC 64727-6150-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034
Affected NDCs
64727-6150-01
64727-6150-02
64727-6150-04
64727-6150-05
64727-6150-06
Compare with the code on your package — it is the most precise check available.
Drug: Thyroid Category: Thyroid Medication
- Recalling firm
- RLC Labs Inc.
- NDC code
- 64727-6150-2
- Origin
- AZ, United States
- Initiated by
- Voluntary: Firm initiated
- FDA recall number
- D-1612-2020 · FDA notice
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Other Thyroid recalls
See all
Class II · Moderate risk
Thyroid
Subpotent Drug
Class II · Moderate risk
S.P Labs
Failed Stability Specifications
Class II · Moderate risk
S.P.Labs
Failed Stability Specifications
Class II · Moderate risk
Levothyroxine 25mcg in Ns 1.25ml Syringe
Lack of sterility assurance
Other recalls by RLC Labs Inc.
All 2020 recalls
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Class I · High risk
Nature Throid
Subpotent Drug: FDA analysis found product to be subpotent
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.